INTRODUCTION
============

In general, autonomic nerve activity regulates cardiac function in a reciprocal manner. However, less understood are the mechanisms by which β-adrenergic receptor (β-AR) stimulation influences the effects of subsequent muscarinic receptor stimulation. Previous work from this laboratory ([Wang and Lipsius 1995](#WangandLipsius1995){ref-type="bib"}) has shown that in atrial myocytes, an initial exposure to isoproterenol (ISO) conditions the cell, such that a subsequent acetylcholine (ACh) exposure elicits a potentiated increase in K^+^ conductance. The additional ACh-activated K^+^ conductance exhibits inward rectification and is blocked by glibenclamide (GLIB), identifying it as ATP-sensitive K^+^ current (I~K,ATP~). Therefore, these findings indicate that after β-AR stimulation, subsequent muscarinic receptor stimulation elicits activation of two separate K^+^ conductances: ACh-activated K^+^ current (I~K,ACh~) and I~K,ATP~. Functionally, this mechanism may contribute to enhanced cholinergic inhibition of atrial function following β-AR stimulation. The conditioning effects of ISO are dependent on cAMP-dependent PKA signaling ([Wang and Lipsius 1995](#WangandLipsius1995){ref-type="bib"}). However, because ISO is a nonselective β-AR agonist, it is not clear whether the effects of ISO are mediated via β1- and/or β~2~-AR subtypes. Both types of β-ARs are present in cat atrial myocytes ([Wang et al. 2000](#Wangetal2000){ref-type="bib"}), and each type exhibits significantly different signal transduction mechanisms ([Steinberg 1999](#Steinberg1999){ref-type="bib"}; [Xiao et al. 1999b](#Xiaoetal1999b){ref-type="bib"}). Although β~1~-ARs are more abundant than β~2~-ARs, the proportion of β~2~- to β~1~-ARs may be greater in atrial than ventricular muscle ([Buxton et al. 1987](#Buxtonetal1987){ref-type="bib"}). In human atrial muscle, the relative proportion of β~2~- to β~1~-ARs has been reported at 20:80 ([Brodde et al. 1983](#Broddeetal1983){ref-type="bib"}) and as high as 50:50 ([Robberecht et al. 1983](#Robberechtetal1983){ref-type="bib"}). β~1~-ARs act exclusively via G~s~-proteins coupled to adenylate cyclase to catalyze the synthesis of cAMP, which in turn activates PKA. β~2~-AR signaling appears more diverse: β~2~-ARs couple to both G~s~- and G~i~-proteins ([Xiao et al. 1995](#Xiaoetal1995){ref-type="bib"}, [Xiao et al. 1999a](#Xiaoetal1999a){ref-type="bib"}; [Kilts et al. 2000](#Kiltsetal2000){ref-type="bib"}). Moreover, in contrast to β~1~-ARs, several studies indicate that β~2~-AR signaling acts locally to regulate L-type Ca^2+^ current (I~Ca,L~) via cAMP/PKA activity, and is uncoupled from nonsarcolemmal regulatory proteins ([Xiao and Lakatta 1993](#XiaoandLakatta1993){ref-type="bib"}; [Xiao et al. 1994](#Xiaoetal1994){ref-type="bib"}; [Altschuld et al. 1995](#Altschuldetal1995){ref-type="bib"}; [Skeberdis et al. 1997](#Skeberdisetal1997){ref-type="bib"}; [Zhou et al. 1997](#Zhouetal1997){ref-type="bib"}; [Kuschel et al. 1999](#Kuscheletal1999){ref-type="bib"}). These findings are consistent with the idea that β-AR regulation of I~Ca,L~ can result from local or compartmentalized changes in cAMP ([Hohl and Li 1991](#HohlandLi1991){ref-type="bib"}; [Jurevičius and Fischmeister 1996](#N0x2f224c0N0x1d449f0){ref-type="bib"}), and that β-adrenergic regulation may correlate more closely with particulate rather than global cAMP levels ([Hohl and Li 1991](#HohlandLi1991){ref-type="bib"}). Much less is known about β~2~-AR signaling in atrial muscle. In contrast to ventricular muscle, β~2~-AR stimulation in human atrial muscle appears to exert global rather than local regulation of cellular functions ([Kaumann et al. 1996](#Kaumannetal1996){ref-type="bib"}).

Another important consideration is that in cardiomyocytes, β-AR stimulation activates NO production ([Kanai et al. 1997](#Kanaietal1997){ref-type="bib"}; [Sterin-Borda et al. 1998](#Sterin-Bordaetal1998){ref-type="bib"}; [Balligand 1999](#Balligand1999){ref-type="bib"}). However, the role of NO signaling in heart depends on a variety of factors such as NO concentration, concurrent β-adrenergic stimulation, tissue type, and animal species ([Balligand 1999](#Balligand1999){ref-type="bib"}). In cat ([Wang et al. 1998](#Wangetal1998){ref-type="bib"}) and human ([Kirstein et al. 1995](#Kirsteinetal1995){ref-type="bib"}) atrial myocytes, NO acts via cGMP-mediated inhibition of phosphodiesterase (PDE) type III activity to enhance cAMP-dependent stimulation of I~Ca,L~. Therefore, the purpose of the present study was twofold: first, to determine whether β~1~- and/or β~2~-ARs are responsible for mediating ACh-induced activation of I~K,ATP~; and second, to determine whether the conditioning effect of β-AR signaling is mediated via NO signaling. The results indicate that even though both β~1~- and β~2~-ARs stimulate cAMP signaling, only β~2~-AR--stimulated cAMP mediated via NO signaling induces ACh to activate I~K,ATP~. The differential effects of β~1~- and β~2~-ARs to regulate ion channel function may be explained by the coupling of different β-AR subtypes to different effector signaling pathways.

MATERIALS AND METHODS
=====================

Atrial myocytes were dispersed from adult cat atria using Langendorff perfusion and collagenase (type II; Worthington Biochemical) digestion as previously reported ([Wu et al. 1991](#Wuetal1991){ref-type="bib"}). No discernible differences were noted between left and right atrial myocytes. Cells used for electrophysiological studies were transferred to a small tissue bath (0.3 ml) on the stage of an inverted microscope (Nikon Diaphot) and superfused with a HEPES-buffered modified Tyrode solution containing the following (in mM): 145 NaCl, 4 KCl, 1 MgCl~2~, 2 CaCl~2~, 5 HEPES, and 11 glucose, and titrated with NaOH to a pH of 7.4. Solutions were perfused by gravity and heated to 35 ± 1°C. Atrial myocytes selected for study were elongated and quiescent. Voltage and ionic currents were recorded using a nystatin (150 μg/ml)-perforated patch ([Horn and Marty 1988](#HornandMarty1988){ref-type="bib"}) whole-cell recording method ([Hamill et al. 1981](#Hamilletal1981){ref-type="bib"}). This method minimizes dialysis of intracellular constituents with the internal pipette solution, and thereby preserves physiological milieu and second messenger signaling pathways. The internal pipette solution contained the following (in mM): 100 potassium glutamate, 40 KCl, 1.0 MgCl~2~, 4 Na~2~-ATP, 0.5 EGTA, and 5 HEPES, and titrated with KOH to pH 7.2. A single suction pipette was used to record voltage (bridge mode) or ionic currents (discontinuous voltage-clamp mode) using an Axoclamp 2A amplifier (Axon Instruments, Inc.). Computer software (Pclamp; Axon Instruments, Inc.) was used to deliver voltage protocols, acquire, and analyze data. The effects of ACh on K^+^ conductance were studied as previously described ([Wang and Lipsius 1995](#WangandLipsius1995){ref-type="bib"}). In brief, an atrial cell was treated with two consecutive exposures to ACh (ACh~1~ and ACh~2~) separated by a 6-min recovery period in ACh-free Tyrode solution (see [Fig. 1](#F1){ref-type="fig"} A). Changes in total membrane conductance were assessed by imposing voltage-clamp ramps (40 mV/s) between −130 and +30 mV before, during, and after each ACh exposure. Voltage ramps offer the advantage of a rapid method for measuring peak ACh-induced currents throughout the voltage range. In general, experimental interventions, such as exposure to ISO, zinterol, or spermine-NO were imposed during the recovery period between ACh~1~ and ACh~2~. In this way, we determined the effect of each intervention on ACh-induced K^+^ conductances by comparing the response to ACh~2~ in relation to ACh~1~. Measurements of K^+^ conductance were obtained at −130 and +30 mV. The effects of each ACh exposure on K^+^ conductance was fully reversible (see [Fig. 1](#F1){ref-type="fig"} A). Previous work indicates that the control currents do not affect the measurement of relative changes in K^+^ conductances induced by ACh~2~ in relation to ACh~1~ ([Wang and Lipsius 1995](#WangandLipsius1995){ref-type="bib"}). Therefore, in this study, ACh-induced K^+^ currents were measured without subtraction of control currents. Control experiments indicate that an initial 30-s exposure to ACh followed by a 6-min recovery period has no effect on the response to a second ACh exposure ([Wang and Lipsius 1995](#WangandLipsius1995){ref-type="bib"}). Therefore, any changes in K^+^ conductance elicited by ACh~2~ in relation to ACh~1~ are attributed to the experimental intervention imposed during the recovery interval. Previous work ([Wang and Lipsius 1995](#WangandLipsius1995){ref-type="bib"}) indicates that Ca^2+^ influx via I~Ca,L~ during β-AR stimulation enhances ACh-induced activation of I~K,ATP~. Therefore, I~Ca,L~ was activated during the interval between ACh exposures by depolarizing voltage pulses from a holding potential of −40 to 0 mV for 200 ms every 10 s. In some experiments, I~Ca,L~ was studied alone by replacing potassium glutamate with cesium glutamate in the pipette solution and adding 5 mM CsCl to the external solutions to block K^+^ conductances. In other experiments, I~Ca,L~ was recorded using a ruptured patch recording method to dialyze the cell interior with PKA inhibitors. PKA inhibitors were allowed to diffuse into the cell for ∼5 min before recordings were performed. In these experiments, the internal pipette solution contained the following (mM): 100 cesium glutamate, 40 CsCl, 1 MgCl~2~, 4 NaATP, 0.5 EGTA, 10 HEPES, and titrated with CsOH to pH 7.2. Unless stated otherwise, zinterol was tested in the presence of 0.01--0.1 μM atenolol to ensure β~2~-AR stimulation. Cells were exposed to receptor antagonists for ∼4 min before exposure to agonists. Inhibition of G~i~-protein was achieved by incubating cells in pertussis toxin (PTX; 3.4 μg/ml; ≥3 h; 36°C) and confirmed by inhibition of ACh-activated I~K,ACh~.

Direct measurements of intracellular NO (\[NO\]~i~) were obtained by incubating cells with the fluorescent NO-sensitive dye 4,5-diaminofluorescein (DAF-2; [Kojima et al. 1998](#Kojimaetal1998){ref-type="bib"}; [Nakatsubo et al. 1998](#Nakatsuboetal1998){ref-type="bib"}). Experiments were performed at room temperature. Cells were exposed to the membrane-permeant DAF-2 diacetate (\[DAF-2 DA\] = 5 μM; Calbiochem) for 10 min at room temperature in 1 ml standard Tyrode solution. Cells were subsequently washed for 10 min in Tyrode solution containing 100 μM [l]{.smallcaps}-arginine. DAF-2 fluorescence was excited at 480 nm (F480). Emitted cellular fluorescence was recorded at 540 nm. Single cell fluorescence signals were recorded with a photomultiplier tube (model R2693; Hamamatsu Corp.) by masking individual cells with an iris positioned in the emission path. Changes in cellular DAF-2 fluorescence intensities (F) in each experiment were normalized to the level of fluorescence recorded before stimulation (F~o~), and changes in \[NO\]~i~ are expressed as F/F~o~. In the experiments designed to measure \[NO\]~i~, solutions contained 100 μM [l]{.smallcaps}-arginine. [l]{.smallcaps}-arginine was omitted when L-NIO was used to block NO synthase.

Drugs in this study include all of the following: isoproterenol, acetylcholine chloride, glibenclamide, atenolol, PK inhibitor (PKI), spermine-NO, [l]{.smallcaps}-N^5^-(1-iminoethyl)ornithine (L-NIO), 1H-\[1,2,4,\]oxadiazolo\[4,3-α\]quinoxaline-1-one (ODQ), Wortmannin, LY294002, pertussis toxin (Sigma Chemicals); Rp-cAMPs, 4,5-diaminofluorescein diacetate (DAF-2 DA; Calbiochem); zinterol (provided by Bristol-Myers Squibb), and ICI 118,551 (provided by AstraZeneca).

In general, results were obtained in cells from the same hearts studied under control and test conditions. Data from two groups of cells were analyzed using unpaired *t* test with significance at *P* ≤ 0.05. Data from multiple groups were analyzed using a one-way analysis of variance (ANOVA) followed by a *t*-Newman-Keuls test at *P* ≤ 0.05.

RESULTS
=======

β-Adrenergic Receptor Subtypes
------------------------------

[Fig. 1](#F1){ref-type="fig"} A shows a typical experiment in which an atrial myocyte was treated with two consecutive 30-s exposures to 10 μM ACh separated by a 6-min recovery period. During the recovery period, the cell was exposed to 0.1 μM ISO, a nonselective β~1~/β~2~-AR agonist, and I~Ca,L~ was activated by voltage-clamp pulses ([materials and methods]{.smallcaps}). As expected, ISO-β~1~/β~2~-AR stimulation elicited a marked increase in peak I~Ca,L~ above basal levels (+258%; [Fig. 1](#F1){ref-type="fig"} A, inset). Both ACh~1~ and ACh~2~ exposures elicited an increase in K^+^ conductance. However, after exposure to ISO, ACh~2~ induced a potentiated increase in K^+^ conductance compared with ACh~1~. As summarized in [Fig. 2](#F2){ref-type="fig"}, ISO-β~1~/β~2~-AR stimulation increased I~Ca,L~ by 266 ± 78%, and ACh~2~ increased K^+^ conductance compared with ACh~1~ by 31 ± 10% (at −130 mV) and 25 ± 3% (at 30 mV), respectively (*n* = 4; *P* \< 0.05). These findings demonstrate that ISO elicits a conditioning effect that potentiates ACh~2~-induced K^+^ conductance as previously reported ([Wang and Lipsius 1995](#WangandLipsius1995){ref-type="bib"}). The potentiated ACh~2~-induced K^+^ conductance has been identified as I~K,ATP~ ([Wang and Lipsius 1995](#WangandLipsius1995){ref-type="bib"}).

To determine whether the conditioning effect of ISO was mediated via β~1~-ARs, the same protocol was repeated by testing 0.1 μM ISO in the presence of 0.01 μM ICI 118,551, a selective β~2~-AR antagonist ([O\'Donnell and Wanstall 1980](#ODonnellandWanstall1980){ref-type="bib"}). As shown in [Fig. 1](#F1){ref-type="fig"} B, ISO-β~1~-AR stimulation increased I~Ca,L~ markedly (372%, inset), but failed to elicit a potentiated increase in ACh~2~-induced K^+^ conductance. In fact, in this experiment, ACh~2~ elicited an increase in K^+^ conductance that was slightly smaller than ACh~1~. As summarized in [Fig. 2](#F2){ref-type="fig"}, ISO-β~1~-AR stimulation increased I~Ca,L~ (239 ± 48%), whereas ACh~2~ failed to elicit a potentiated increase in K^+^ conductance compared with ACh~1~ (1 ± 4% at −130 mV, and 0.5 ± 3%, 30 mV; *n* = 8). In other words, ACh~1~ and ACh~2~ exposures induced essentially the same increase in K^+^ conductance, indicating that ISO did not affect I~K,ACh~. Similar results were obtained when the concentration of ISO was raised to 1 μM (in the presence of 0.1 μM ICI 118,551), i.e., stimulation of I~Ca,L~ (395%) without potentiation of ACh~2~-induced K^+^ conductance (*n* = 3).

To determine whether the effects of ISO are mediated via β~2~-AR signaling, we tested the effects of ISO plus 0.01 μM atenolol, a selective β~1~-AR antagonist. [Fig. 1](#F1){ref-type="fig"} C shows that ISO-β~2~-AR stimulation increased I~Ca,L~ (248%, inset) and mediated a potentiated increase in ACh~2~-induced K^+^ conductance. As summarized in [Fig. 2](#F2){ref-type="fig"}, ISO-β~2~-AR stimulation increased I~Ca,L~ by 199 ± 50% and ACh~2~ increased K^+^ conductance compared with ACh~1~ by 27 ± 6% (−130 mV) and 29 ± 3% (30 mV; *P* \< 0.05; *n* = 7). Additional experiments showed that 10 μM glibenclamide, an inhibitor of I~K,ATP~, abolished the effect of ISO-β~2~-AR stimulation to potentiate the ACh~2~-induced K^+^ conductance (−2 ± 9% at −130 mV, and 0.5 ± 5% at 30 mV) without affecting stimulation of I~Ca,L~ (220 ± 58%; *n* = 4; not shown). This finding is consistent with ACh~2~-induced activation of I~K,ATP~, as previously reported ([Wang and Lipsius 1995](#WangandLipsius1995){ref-type="bib"}). The combined presence of β~1~-AR (0.1 μM atenolol) and β~2~-AR (0.1 μM ICI 118,551) antagonists abolished the effects of 0.1 μM ISO to both stimulate I~Ca,L~ (20 ± 5%) and mediate ACh-activated I~K,ATP~ (4 ± 10% at −130 mV, and 0 ± 3% at 30 mV; *n* = 3). Further experiments showed that 0.01 μM BRL 37344, a β~3~-AR agonist ([Gauthier et al. 1999](#Gauthieretal1999){ref-type="bib"}) failed to stimulate I~Ca,L~ or mediate ACh-activated I~K,ATP~ (*n* = 5; not shown).

To further establish that selective β~2~-AR signaling is responsible for the conditioning effect, we tested zinterol, a selective β~2~-AR agonist. As shown in [Fig. 1](#F1){ref-type="fig"} D, 1 μM zinterol increased I~Ca,L~ (273%; inset) and mediated ACh~2~-induced activation of I~K,ATP~. As summarized in [Fig. 2](#F2){ref-type="fig"}, zinterol increased I~Ca,L~ by 159 ± 17% and increased ACh~2~-induced K^+^ conductance compared with ACh~1~ by 36 ± 7% (−130 mV) and 28 ± 5% (30 mV; *P* \< 0.05; *n* = 16). To confirm that zinterol acted via β~2~-AR stimulation, 1 μM zinterol was tested in the presence of 0.01 μM ICI 118,551. Interestingly, this relatively low concentration of ICI 118,551 abolished the effects of zinterol to mediate ACh~2~-activated I~K,ATP~ (\[control\] 23 ± 3% vs. \[ICI\] −12 ± 6% at −130 mV; and \[control\] 31 ± 5% vs. \[ICI\] −1 ± 3% at 30 mV) but only attenuated zinterol-induced stimulation of I~Ca,L~ (\[control\] 193 ± 84 vs. \[ICI\] 160 ± 43%; not shown). Raising the concentration of ICI 118,551 to 1 μM also abolished zinterol-induced stimulation of I~Ca,L~ (\[control\] 180% vs. \[ICI\] 0.2%; *n* = 6; not shown). These latter findings indicate that the sensitivity of β~2~-ARs to mediate stimulation of I~Ca,L~ is greater than to mediate ACh-activated I~K,ATP~. This idea was explored further by testing a lower (0.1 μM) zinterol concentration. As summarized in [Fig. 2](#F2){ref-type="fig"}, 0.1 μM zinterol induced a typical increase in I~Ca,L~ (152 ± 31%), but failed to elicit a potentiated increase in ACh~2~-induced K^+^ conductance compared with ACh~1~ (−2 ± 2% at −130 mV, and 1 ± 3% at 30 mV; *n* = 6). Together, these results indicate that although stimulation of β~1~- or β~2~-ARs both increase I~Ca,L~ markedly, only β~2~-AR signaling selectively mediates ACh~2~-induced activation of I~K,ATP~. In addition, the effects of β~2~-AR stimulation to mediate ACh-induced activation of I~K,ATP~ and stimulate I~Ca,L~ exhibit different signaling sensitivities. Finally, β~3~-ARs do not participate in the conditioning effect of β-AR stimulation.

Nitric Oxide Signaling
----------------------

β-AR stimulation can induce NO release in cardiac myocytes ([Kanai et al. 1997](#Kanaietal1997){ref-type="bib"}). Therefore, we sought to determine whether the conditioning effect of β~2~-AR stimulation is mediated via NO signaling by testing zinterol in the presence of 10 μM L-NIO, an inhibitor of constitutive NO synthase ([Rees et al. 1990](#Reesetal1990){ref-type="bib"}). The graph in [Fig. 3](#F3){ref-type="fig"} A shows that in the absence of L-NIO (open bars), zinterol elicited a typical increase in I~Ca,L~ (150 ± 21%) and a potentiated increase in ACh~2~-induced K^+^ conductance (52 ± 20% at −130 mV, and 40 ± 15% at 30 mV). In a second group of cells from the same hearts, in the presence of L-NIO ([Fig. 3](#F3){ref-type="fig"} A, hatched bars), zinterol-induced stimulation of I~Ca,L~ was attenuated (121 ± 31%), whereas ACh~2~-induced activation of I~K,ATP~ was abolished (−6 ± 2% at −130 mV, and −7 ± 2% at 30 mV) (*n* = 12; *P* \< 0.05).

To determine whether NO signaling acts via cGMP, we tested zinterol in the presence of 30 μM ODQ, an inhibitor of soluble guanylate cyclase ([Garthwaite et al. 1995](#Garthwaiteetal1995){ref-type="bib"}). The graph in [Fig. 3](#F3){ref-type="fig"} B shows that compared with control cells, ODQ also attenuated zinterol-induced stimulation of I~Ca,L~ (\[control\] 177 ± 27% vs. \[ODQ\] 111 ± 13%) and abolished ACh~2~-induced activation of I~K,ATP~ (\[control\] 27 ± 4% vs. \[ODQ\] 2 ± 2% at −130 mV; and \[control\] 25 ± 3% vs. \[ODQ\] 4 ± 1% at 30 mV) (*n* = 13; *P* \< 0.05).

If the conditioning effect of β~2~-AR stimulation results from NO signaling, then exogenous NO should qualitatively mimic the effects of β~2~-AR stimulation. Spermine-NO (SNO) spontaneously releases NO without the production of other biologically active byproducts or intermediates ([Maragos et al. 1991](#Maragosetal1991){ref-type="bib"}). 100 μM SNO stimulated basal I~Ca,L~ as previously reported ([Wang et al. 1998](#Wangetal1998){ref-type="bib"}), and mediated a potentiated increase in ACh~2~-induced K^+^ conductance compared with ACh~1~ ([Fig. 4](#F4){ref-type="fig"} A). In a total of six cells, SNO increased I~Ca,L~ by 240 ± 52% and potentiated ACh~2~-induced K^+^ conductance by 32 ± 7% (−130 mV) and 26 ± 5% (30 mV; *P* \< 0.05). Moreover, 10 μM GLIB had no significant effect on SNO-induced stimulation of I~Ca,L~, but as shown in [Fig. 4](#F4){ref-type="fig"} B, it abolished ACh~2~-induced potentiation of K^+^ conductance (\[control\] 32 ± 5% vs. \[GLIB\] −1 ± 2% at −130 mV; and \[control\] 30 ± 7% vs. \[GLIB\] −6 ± 7% at 30 mV) (*n* = 8; *P* \< 0.05). Note that at positive voltages, ACh~2~-induced K^+^ conductance was slightly smaller than that induced by ACh~1~. These findings demonstrate that exogenous NO mimics the effects of β~2~-AR stimulation by stimulating I~Ca,L~ and mediating ACh~2~-induced activation of I~K,ATP~. Together, these results indicate that β~2~-AR stimulation acts via NO-cGMP signaling to mediate ACh~2~-induced activation of I~K,ATP~. In addition, NO signaling contributes to β~2~-AR stimulation of I~Ca,L~.

In cat atrial myocytes, NO-cGMP signaling enhances cAMP by inhibiting PDE type III activity ([Wang et al. 1998](#Wangetal1998){ref-type="bib"}). To determine whether β~2~-AR--stimulated NO signaling acts via cAMP to mediate ACh-induced activation of I~K,ATP~, we tested the effects of 100 μM SNO and 1 μM zinterol in the absence and presence of 50 μM Rp-cAMPs, an inhibitor of cAMP-dependent PKA activity ([Van Haastert et al. 1984](#VanHaastertetal1984){ref-type="bib"}). In these experiments, cells were externally superfused with Rp-cAMPs. The graph in [Fig. 5](#F5){ref-type="fig"} A shows that compared with control cells (open bars), Rp-CAMPs abolished SNO-induced stimulation of both I~Ca,L~ (\[control\] 240 ± 52% vs. \[Rp-cAMPs\] 9 ± 8%) and ACh~2~-activated I~K,ATP~ (32 ± 7% vs. 0 ± 3% at −130 mV, and 26 ± 5% vs. 5 ± 3% at 30 mV; *P* \< 0.05). Interestingly, when the same experiment was performed with zinterol, compared with control responses (open bars), Rp-cAMPs only attenuated zinterol-induced stimulation of I~Ca,L~ (\[control\] 123 ± 24% vs. \[Rp-cAMPs\] 98 ± 25%) while completely blocking ACh~2~-induced activation of I~K,ATP~ (29 ± 5% vs. 0 ± 1% at −130 mV; and 19 ± 2% vs. 1 ± 2% at 30 mV) (*n* = 14; *P* \< 0.05). These results indicate that inhibition of cAMP-dependent PKA by Rp-cAMPs effectively abolishes NO-mediated signaling. Moreover, NO signaling stimulated by β~2~-ARs acts via cAMP to mediate ACh-induced activation of I~K,ATP~ and contributes to stimulation of I~Ca,L~. The fact that inhibition of PKA abolished SNO-induced stimulation of I~Ca,L~ but only attenuated β~2~-AR stimulation of I~Ca,L~ suggests that β~2~-AR signaling regulates I~Ca,L~, in large part, via a mechanism that is independent of NO signaling.

In other words, after blockade of NO signaling, β~2~-AR stimulation still stimulates I~Ca,L~ by at least 100% above basal levels. This NO-independent effect of β~2~-AR stimulation could still be mediated by cAMP. It may not be inhibited by Rp-cAMPs because external application of Rp-cAMPs cannot reach high enough levels intracellularly to compete with cAMP and/or to access a separate cAMP compartment. To address this issue, we determined the effect of zinterol to regulate I~Ca,L~ using a ruptured patch method to dialyze the cell interior with either 100 μM Rp-cAMPs or 20 μM cAMP-dependent PKA inhibitory peptide (PKI). This method allows better access to intracellular compartments and achieves a higher concentration of inhibitor intracellularly. Cells dialyzed without (control) and with drugs were compared. Intracellular Rp-cAMPs elicited a significantly greater inhibition of 1 μM zinterol-induced stimulation of I~Ca,L~ (\[control\] 140 ± 32% vs. \[Rp-cAMPs\] 54 ± 11%) (*n* = 10; *P* \< 0.05; not shown). In addition, intracellular PKI essentially abolished the effect of 1 μM zinterol to stimulate I~Ca,L~ (\[control\] 188 ± 17% vs. \[Rp-cAMPs\] 18 ± 6%; *n* = 6; *P* \< 0.05) and almost completely blocked 0.1 μM ISO-induced stimulation of I~Ca,L~ (\[control\] 176 ± 27% vs. \[PKI\] 25 ± 6%) (*n* = 6; *P* \< 0.05; not shown). These findings indicate that β~2~-AR stimulation of I~Ca,L~ is mediated entirely via cAMP. Therefore, the β~2~-AR--mediated stimulation of I~Ca,L~ that remains after blockade of NO signaling is mediated via cAMP. Together, the present findings suggest that β~2~-ARs generate cAMP via two different signaling pathways; NO-dependent and NO-independent.

Intracellular Nitric Oxide Release
----------------------------------

In the following experiments, we used the NO indicator DAF-2 to directly visualize changes in intracellular NO concentration (\[NO\]~i~). [Fig. 6](#F6){ref-type="fig"} (A--D) shows the effects of 1 μM ISO (β~1~/β~2~-AR stimulation, [Fig. 6](#F6){ref-type="fig"} A), 1 μM ISO in the presence of 0.1 μM atenolol (β~2~-AR stimulation, [Fig. 6](#F6){ref-type="fig"} B), 1 μM ISO in the presence of 0.1 μM ICI 118,551 (β~1~-AR stimulation, [Fig. 6](#F6){ref-type="fig"} C), and 1 μM ISO in the presence of 10 μM L-NIO ([Fig. 6](#F6){ref-type="fig"} D). In each experiment, the cells were field-stimulated at 1 Hz. ISO alone ([Fig. 6](#F6){ref-type="fig"} A) and ISO-β~2~-AR stimulation ([Fig. 6](#F6){ref-type="fig"} B) both increased \[NO\]~i~. ISO-β~1~-AR stimulation ([Fig. 6](#F6){ref-type="fig"} C) failed to increase \[NO\]~i~. However, exposure to 100 μM SNO elicited a prominent increase in \[NO\]~i~, indicating that the NO indicator was functional ([Fig. 6](#F6){ref-type="fig"} C). ISO-mediated stimulation of \[NO\]~i~ was abolished by pretreatment with 10 μM L-NIO ([Fig. 6](#F6){ref-type="fig"} D). These findings indicate that ISO acts via β~2~-ARs, but not β~1~-ARs, to activate NO release. As shown in [Fig. 7](#F7){ref-type="fig"} (A--D) the effects of β~2~-AR stimulation on \[NO\]~i~ was further examined by testing zinterol. [Fig. 7](#F7){ref-type="fig"} A shows that field stimulation (FS, arrow) alone had no effect on \[NO\]~i~. During field stimulation, however, exposure to 10 μM zinterol increased \[NO\]~i~ ([Fig. 7](#F7){ref-type="fig"} A). Zinterol-mediated increases in \[NO\]~i~ were abolished by blocking β~2~-ARs with ICI 118,551 ([Fig. 7](#F7){ref-type="fig"} B) or by blocking NOS with 10 μM L-NIO ([Fig. 7](#F7){ref-type="fig"} C). [Fig. 7](#F7){ref-type="fig"} D shows the effects of three different zinterol concentrations (10, 1, and 0.1 μM) on \[NO\]~i~. Zinterol induced a dose-dependent increase in \[NO\]~i~. The graph in [Fig. 8](#F8){ref-type="fig"} (A and B) summarizes the effects of 1 μM ISO and 10 μM zinterol on \[NO\]~i~ ([Fig. 8](#F8){ref-type="fig"} A) and the dose-dependent effects of zinterol ([Fig. 8](#F8){ref-type="fig"} B). Both ISO and zinterol increased \[NO\]~i~ (open bars). Although each response was slightly decreased by 0.1 μM atenolol, compared with control, the differences were not statistically significant. This concentration of atenolol may have exerted some β~2~-AR blockade. Nevertheless, the effects of ISO and zinterol were abolished by β~2~-AR blockade (0.1 μM ICI 118,551) or inhibition of NOS (10 μM L-NIO). [Fig. 8](#F8){ref-type="fig"} B summarizes the dose--response for the three different zinterol concentrations tested. At 0.1 μM zinterol, only three out of six cells elicited a small increase in \[NO\]~i~. Further experiments showed that the β~3~-AR agonist BRL 37344 (0.01 μM) failed to increase \[NO\]~i~ (not shown). Together, these findings are consistent with the present electrophysiological findings that stimulation of β~2~-ARs, but not β~1~-ARs or β~3~-ARs, act via NO signaling to mediate ACh-induced activation of I~K,ATP~ and to stimulate I~Ca,L~.

Finally, we sought to gain further insight into the signaling pathway through which β~2~-ARs stimulate NO production and mediate ACh-induced activation of I~K,ATP~. We determined whether the effect of β~2~-ARs to release NO is mediated via G~i~-protein by testing cells incubated in PTX ([materials and methods]{.smallcaps}). [Fig. 9](#F9){ref-type="fig"} A shows the effect of 10 μM zinterol on a control cell and second cell obtained from the same heart incubated in PTX. Under control conditions, zinterol elicited a typical increase in \[NO\]~i~. In the PTX-treated cell, zinterol-induced stimulation of NO production was markedly decreased. The graph in [Fig. 9](#F9){ref-type="fig"} B summarizes the effects of zinterol to increase \[NO\]~i~ in control (1.1 ± 0.02; *n* = 9) and PTX-treated cells (1.0 ± 0.01; *n* = 17), and shows that compared with control, pretreatment with PTX significantly (*P* \< 0.001) inhibited zinterol-induced stimulation of NO. These findings suggest that β~2~-ARs act via G~i~-protein to stimulate NO release.

In endothelial cells, stimulation of phosphatidylinositol 3′-kinase (PI-3K) signaling activates AKt (PKB)-mediated phosphorylation of eNOS, resulting in the production of NO ([Dimmeler et al. 1999](#Dimmeleretal1999){ref-type="bib"}; [Fulton et al. 1999](#Fultonetal1999){ref-type="bib"}). To examine the role of PI-3K, we incubated atrial cells in 0.2 μM Wortmannin, an inhibitor of PI-3K, for ∼30--45 min. In a control cell ([Fig. 10](#F10){ref-type="fig"} A), 1 μM zinterol mediated a typical ACh~2~-induced activation of I~K,ATP~. In another cell from the same heart ([Fig. 10](#F10){ref-type="fig"} B), pretreatment with Wortmannin abolished the effect of zinterol to mediate ACh~2~-induced activation of I~K,ATP~. Comparing control (*n* = 3) and Wortmannin-treated cells (*n* = 4) showed that Wortmannin (wort) abolished the potentiated increase in ACh~2~-induced K^+^ conductance (\[control\] 37 ± 8% vs. \[wort\] 0.3 ± 1% at −130 mV; and \[control\] 36 ± 11% vs. \[wort\] 4 ± 4% at 30 mV) (*P* \< 0.05). Additional experiments showed that 10 μM LY294002 (LY), a specific PI-3K inhibitor that acts via a different mechanism than Wortmannin ([Vlahos et al. 1994](#Vlahosetal1994){ref-type="bib"}), also abolished the potentiated increase in ACh~2~-induced K^+^ conductance (\[control\] 18 ± 2% vs. \[LY\] −0.1 ± 2% at −130 mV; and \[control\] 24 ± 4% vs. \[LY\] −7 ± 1% at 30 mV) (*n* = 8; *P* \< 0.05; not shown). Furthermore, as shown in [Fig. 10](#F10){ref-type="fig"} C, in a control cell, 10 μM zinterol increased \[NO\]~i~ and in a cell pretreated with Wortmannin, the zinterol-mediated increase in \[NO\]~i~ was abolished. As summarized in [Fig. 10](#F10){ref-type="fig"} D, compared with control (1.2 ± 0.5; *n* = 4), Wortmannin (1.0 ± 0.2; *n* = 3) or LY294002 (0.9 ± 02; *n* = 5; *P* \< 0.05) abolished zinterol-mediated increases in \[NO\]~i~. These findings indicate that β~2~-ARs act via PI-3K signaling to activate NO production that, in turn, mediates ACh-activated I~K,ATP~.

DISCUSSION
==========

Our previous work indicates that in cat atrial myocytes, an initial exposure to ISO acts via cAMP signaling to mediate a subsequent ACh-induced activation of I~K,ATP~ ([Wang and Lipsius 1995](#WangandLipsius1995){ref-type="bib"}). The present findings extend our previous work by elucidating several new underlying mechanisms: (1) the conditioning effect of β-AR stimulation acts selectively via β~2~-ARs rather than the predominant β~1~-AR signaling pathway; (2) β~2~-ARs act via G~i~-protein and PI-3K coupled to NO-cGMP-cAMP signaling to mediate ACh-induced activation of I~K,ATP~; and (3) NO signaling contributes to β~2~-AR stimulation of I~Ca,L~. In addition, to the best of our knowledge, this is the first report in adult atrial myocytes to demonstrate direct measurements of \[NO\]~i~, and that G~i~-protein and PI-3K signaling are coupled to NO production.

Perhaps one of the most surprising findings of the present study is that although β~1~- and β~2~-AR subtypes both stimulate cAMP, only cAMP stimulated by β~2~-ARs mediated ACh-activated I~K,ATP~. Moreover, only cAMP generated via NO signaling could mediate ACh-activated I~K,ATP~. The fact that β~2~-AR--mediated stimulation of I~Ca,L~ and ACh-activated I~K,ATP~ could be regulated, to a large extent, independently of one another suggests that β~2~-ARs act via two different signaling pathways. Indeed, partial blockade of PKA activity (Rp-cAMPs), or β~2~-ARs (ICI 118,551), or complete block of NO signaling (L-NIO or ODQ) abolished ACh-activated I~K,ATP~, whereas β~2~-AR stimulation of I~Ca,L~ persisted. Similarly, low concentrations of zinterol stimulated I~Ca,L~ without inducing ACh-activated I~K,ATP~. The ability of β~2~-ARs to stimulate I~Ca,L~ without mediating ACh-activated I~K,ATP~ is essentially the same as the response to β~1~-AR stimulation. Because β~1~-ARs are exclusively coupled via G~s~-proteins to adenylate cyclase ([Barr et al. 1997](#Barretal1997){ref-type="bib"}), it seems reasonable to assume that the β~2~-AR signaling pathway that acts independently of NO signaling also is mediated via G~s~-adenylate cyclase. This is supported by the present findings that inhibition of cAMP-dependent PKA (dialysis with PKI) abolished β~2~-AR--mediated stimulation of I~Ca,L~. Therefore, we conclude that β~2~-ARs stimulate cAMP via two distinct signaling pathways: (1) G~s~-protein coupled directly to adenylate cyclase, which is NO-independent; and (2) NO-cGMP--mediated inhibition of PDE type III activity ([Fig. 11](#F11){ref-type="fig"}The latter pathway is consistent with our previous work in cat atrial myocytes, which indicates that NO signaling stimulates I~Ca,L~ via cGMP-mediated inhibition of PDE type III ([Wang et al. 1998](#Wangetal1998){ref-type="bib"}).

The present work further indicates that stimulation of G~s~-adenylate cyclase by either β~1~- or β~2~-ARs generates a pool of cAMP that is unable to mediate ACh-induced activation of I~K,ATP~. In other words, stimulation of G~s~-adenylate cyclase and NO signaling generate distinct compartments of cAMP. It is now well established that compartmentation of signaling molecules by scaffolding proteins can localize signaling mechanisms to specific intracellular sites ([Couet et al. 1997](#Couetetal1997){ref-type="bib"}; [Okamoto et al. 1998](#Okamotoetal1998){ref-type="bib"}; [Steinberg and Brunton 2001](#SteinbergandBrunton2001){ref-type="bib"}). For example, caveolin contained within caveolae membranes acts to anchor several important signaling components such as β~2~-ARs, Gα subunits, eNOS, and isoforms of adenylate cyclase and PKC. In contrast, β~1~-ARs are thought to be largely excluded from caveolae ([Steinberg and Brunton 2001](#SteinbergandBrunton2001){ref-type="bib"}). Moreover, other signaling components that exist in fixed spacial domains, such as A-kinase anchoring proteins, PKA regulatory subunits, phosphodiesterases, and phosphoprotein phosphatases, target cAMP signaling ([Steinberg and Brunton 2001](#SteinbergandBrunton2001){ref-type="bib"}). Indeed, [Jurevičius and Fischmeister 1996](#N0x2f224c0N0x1d449f0){ref-type="bib"} demonstrated that in frog ventricular myocytes, β-AR stimulation by ISO acts locally to stimulate I~Ca,L~ via local elevation of cAMP, and that local PDE activity targets cAMP signaling to the channel. In the present study, the fact that exogenous NO, which is expected to raise global NO levels, mimicked the effects of β~2~-receptor--mediated stimulation suggests that NO signaling targets specific PDE III activity colocalized with PKA to target cAMP locally generated by endogenous adenylate cyclase activity ([Fig. 11](#F11){ref-type="fig"}). This is consistent with localized regulation by NO signaling ([Dittrich et al. 2001](#Dittrichetal2001){ref-type="bib"}). Moreover, inhibition of phosphodiesterase activities reduces the local response to β-adrenergic stimulation ([Hohl and Li 1991](#HohlandLi1991){ref-type="bib"}; [Jurevičius and Fischmeister 1996](#N0x2f224c0N0x1d449f0){ref-type="bib"}). This may explain why NO signaling induces ACh-activated I~K,ATP~ as well as some stimulation of I~Ca,L~. It is interesting to note that unlike β~1~-AR stimulation, forskolin, a direct stimulator of adenylate cyclase, or 8-CPT-cAMP, a membrane-permeant analogue of cAMP, both elicit ACh-induced activation of I~K,ATP~ equivalent to that of β~2~-AR stimulation ([Wang and Lipsius 1995](#WangandLipsius1995){ref-type="bib"}). Apparently, by raising intracellular cAMP to unphysiologically high levels, these agents probably flood restricted signaling compartments obscuring the delicate regulatory mechanisms that normally exist within the cell. This interpretation is supported by the findings that local application of ISO elicits local stimulation of I~Ca,L~, whereas a similar exposure to forskolin stimulates I~Ca,L~ throughout the cell ([Jurevičius and Fischmeister 1996](#N0x2f224c0N0x1d449f0){ref-type="bib"}).

In the present study, only β~2~-AR signaling activated NO release. In rat ventricular myocytes both, β~1~- and β~2~-ARs stimulate NO release with β~1~-ARs being more effective than β~2~-ARs ([Kanai et al. 1997](#Kanaietal1997){ref-type="bib"}). In rat atria, ISO stimulates NOS activity and the production of cGMP ([Sterin-Borda et al. 1998](#Sterin-Bordaetal1998){ref-type="bib"}), although different β-AR subtypes were not studied. The present results also indicate that stimulation of β~3~-ARs failed to stimulate I~Ca,L~ or mediate ACh-activated I~K,ATP~, suggesting that this β-AR subtype is not involved in the conditioning effect of β-AR stimulation. In various animal species, including human ([Gauthier et al. 1999](#Gauthieretal1999){ref-type="bib"}), stimulation of β~3~-ARs in ventricular muscle decreases contractility and in humans is presumably mediated via activation of an NOS pathway ([Gauthier et al. 1998](#Gauthieretal1998){ref-type="bib"}). The lack of β~3~-AR response in cat atria may be species-dependent and/or due to differences between atrial and ventricular muscle. NO signaling also exerts both negative as well as positive effects on β-adrenergic stimulation depending on various factors such as NO concentration, tissue type, and animal species ([Balligand 1999](#Balligand1999){ref-type="bib"}). The present results show that inhibition of NO signaling attenuated β~2~-AR--induced stimulation of I~Ca,L~, indicating that NO contributes to the stimulatory effects of β~2~-AR signaling. This is consistent with the effects of NO signaling in both cat ([Wang et al. 1998](#Wangetal1998){ref-type="bib"}) and human ([Kirstein et al. 1995](#Kirsteinetal1995){ref-type="bib"}) atrial muscle to stimulate I~Ca,L~ via cGMP-mediated inhibition of PDE type III and elevation of cAMP.

The present results also demonstrate that β~2~-ARs stimulate NO production via PTX-sensitive G~i~-protein, which is consistent with reports that β~2~-ARs are coupled to both G~s~- and G~i~-proteins ([Xiao et al. 1995](#Xiaoetal1995){ref-type="bib"}, [Xiao et al. 1999a](#Xiaoetal1999a){ref-type="bib"}; [Kilts et al. 2000](#Kiltsetal2000){ref-type="bib"}). In addition, the ability of β~2~-ARs to mediate both stimulation of NO and ACh-induced activation of I~K,ATP~ was abolished by blocking PI-3K signaling with either Wortmannin or LY294002. In endothelial cells, Akt is a downstream effector of PI-3K signaling, and can phosphorylate eNOS and stimulate production of NO ([Fulton et al. 1999](#Fultonetal1999){ref-type="bib"}). Inhibition of PI-3K/Akt signaling or mutation of Akt sites on eNOS prevents activation of eNOS ([Dimmeler et al. 1999](#Dimmeleretal1999){ref-type="bib"}). In fact, after submission of the present study, [Vila Petroff et al. 2001](#VilaPetroffetal2001){ref-type="bib"} reported, in rat ventricular myocytes, that stretch-induced release of endogenous NO is mediated via PI-3K/Akt signaling. Moreover, in rat neonatal ventricular myocytes, β~2~-AR stimulation protects from apoptosis via PI-3K/Akt signaling ([Chesley et al. 2000](#Chesleyetal2000){ref-type="bib"}). PI-3K/Akt signaling and protection from apoptosis were prevented by inhibition of G~i~-protein (PTX), indicating that β~2~-ARs act via G~i~- to mediate PI-3K/Akt signaling. Therefore, we conclude that in cat atrial myocytes β~2~-ARs are coupled via G~i~-protein and PI-3K/Akt signaling to eNOS and the production of NO ([Fig. 11](#F11){ref-type="fig"}). This would explain the present finding that β~1~-ARs, which couple exclusively to G~s~-protein, fail to mediate NO release. In addition, activation of PI-3K/Akt signaling is associated with enhanced cell survival ([Kennedy et al. 1997](#Kennedyetal1997){ref-type="bib"}; [Datta et al. 1999](#Dattaetal1999){ref-type="bib"}), and NO signaling is a key mechanism in the cardioprotection conferred by ischemic preconditioning ([Ping et al. 1999](#Pingetal1999){ref-type="bib"}). Therefore, we speculate that β~2~-AR stimulation acts via NO signaling to exert cardioprotective and/or antiapoptotic effects.

The effect of ISO to mediate ACh-activated I~K,ATP~ is enhanced by Ca^2+^ influx via I~Ca,L~ and is dependent on Ca^2+^ uptake and release from the SR ([Wang and Lipsius 1995](#WangandLipsius1995){ref-type="bib"}). Based on these findings, we previously proposed that the conditioning effect of β-AR stimulation depended on cAMP to stimulate Ca^2+^ handling. However, this idea is difficult to reconcile with the present findings, which show that only cAMP generated exclusively via β~2~-AR--mediated NO signaling is capable of inducing ACh-activated I~K,ATP~. In other words, β~1~-AR stimulation of cAMP would certainly be expected to stimulate Ca^2+^ handling, and yet it fails to mediate ACh-induced activation of I~K,ATP~. Therefore, it appears that local NO-cAMP signaling must target additional sites that are more intimately related to cholinergic regulation of ATP-sensitive K^+^ channels.

The present findings indicate that stimulation of the NO-dependent signaling pathway through which β~2~-ARs mediate ACh-activated I~K,ATP~ is less sensitive than the NO-independent (G~s~-) signaling pathway through which β~2~-ARs primarily regulate I~Ca,L~. NO production may need to reach a critical threshold before it can raise cAMP concentrations sufficiently. This is supported by the present finding that although low concentrations of zinterol (0.1 μM) were capable of generating small amounts of \[NO\]~i~, they failed to mediate ACh-induced activation of I~K,ATP~. A similar argument could not explain the inability of ISO-β~1~-AR stimulation to elicit ACh-activated I~K,ATP~ or stimulate \[NO\]~i~ because 1 μM ISO should have maximally stimulated β~1~-ARs ([Marsh and Smith 1985](#MarshandSmith1985){ref-type="bib"}). Functionally, the lower sensitivity of β~2~-AR--mediated NO signaling indicates that this mechanism is probably invoked in response to relatively high levels of β-AR stimulation. As a result, β~2~-AR--mediated NO signaling would augment stimulation of I~Ca,L~ and, at the same time, condition the cell for subsequent enhanced cholinergic inhibition of atrial function via ACh-induced activation of I~K,ATP~. Estimates indicate that ∼1 nS/cell or \<1% of the available conductance of ATP-sensitive K^+^ channels is sufficient to shorten action potential duration by 50% ([Nichols and Lederer 1991](#NicholsandLederer1991){ref-type="bib"}). In the present study, I~K,ATP~ activated by ACh represents an additional K^+^ conductance of ∼2--4 nS/cell (at 0 mV). This should elicit a profound shortening in action potential duration, resulting in a strong negative inotropic response and rapid termination of prior β-AR stimulation. This rapid termination may provide some protection from Ca^2+^ overload that could result from β-adrenergic-induced Ca^2+^ influx.
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![Current-voltage relationships showing the effects of 0.1 μM ISO (A--C) and 1 μM zinterol (D) on ACh~2~-induced K^+^ conductance and I~Ca,L~ (insets). (A) ISO increased I~Ca,L~ and mediated a potentiated increase in ACh~2~-induced K^+^ conductance compared with ACh~1~. (B) In the presence of 0.01 μM ICI 118,551, a β~2~-AR antagonist, ISO increased I~Ca,L~, but failed to potentiate ACh~2~-induced K^+^ conductance. (C) In the presence of 0.01 μM atenolol, a β~1~-AR antagonist, ISO increased I~Ca,L~ and potentiated ACh~2~-induced K^+^ conductance. (D) Zinterol increased I~Ca,L~ and potentiated ACh~2~-induced K^+^ conductance. c; control K^+^ conductance before ACh~1~. r; recovery after washout of ACh~2~. (insets) I~Ca,L~ calibration bars indicate 250 pA, 100 ms.](JGP8486.f1){#F1}

![Summary of the effects of ISO (0.1 μM) and zinterol (0.1 and 1 μM) on I~Ca,L~ and ACh~2~-induced K^+^ conductances measured at −130 and 30 mV. ISO-β~1~/β~2~-AR, ISO-β~1~-AR or ISO-β~2~-AR stimulation each increased I~Ca,L~ and only ISO-β~1~-AR stimulation failed to potentiate ACh~2~-induced K^+^ conductances. In addition, even though 0.1 and 1 μM zinterol increased I~Ca,L~, the lower concentration of zinterol (0.1 μM) failed to potentiate ACh~2~-induced K^+^ conductance. (left ordinate) Percent change in I~Ca,L~ above basal levels. (right ordinate) Percent change in K^+^ conductance elicited by ACh~2~ compared with ACh~1~.](JGP8486.f2){#F2}

![Effects of 1 μM zinterol on I~Ca,L~ and ACh~2~-induced K^+^ conductances in the absence (open bars) and presence (hatched bars) of 10 μM L-NIO (A), an inhibitor of NO synthase, and 10 μM ODQ (B), an inhibitor of soluble guanylate cyclase. L-NIO (A) and ODQ (B) each attenuated zinterol-induced stimulation of I~Ca,L~ and abolished the potentiation of ACh~2~-induced K^+^ conductances. Ordinates are the same as in [Fig. 2](#F2){ref-type="fig"}.](JGP8486.f3){#F3}

![Current-voltage relationships showing the effects of 100 μM spermine-NO (SNO) on ACh-induced K^+^ conductances in the absence (A) and presence (B) of 10 μM glibenclamide (GLIB). (A) SNO elicited a potentiated increase in ACh~2~-induced K^+^ conductance. (B) GLIB blocked the effect of SNO to mediate a potentiated increase in ACh~2~-induced K^+^ conductance. In the experiment shown, at positive voltages, ACh~2~-induced K^+^ conductance was slightly smaller than ACh~1~. c; control K^+^ conductance before ACh~1~.](JGP8486.f4){#F4}

![Effects of spermine-NO (SNO; A) and zinterol (ZINT; B) on I~Ca,L~ and ACh~2~-induced K^+^ conductances in the absence (open bars) and presence (hatched bars) of 50 μM Rp-cAMPs. (A) Rp-cAMPs abolished the effects of 100 μM SNO to both increase I~Ca,L~ and to mediate a potentiated increase in ACh~2~-induced K^+^ conductance. (B) Rp-cAMPs attenuated the effect of 1 μM zinterol to increase I~Ca,L~ and abolished the effect of zinterol to mediate a potentiated increase in ACh~2~-induced K^+^ conductance. Ordinates are the same as in [Fig. 2](#F2){ref-type="fig"}.](JGP8486.f5){#F5}

![Effects of 1 μM ISO on \[NO\]~i~. (A) ISO-β~1~/β~2~-AR stimulation increased \[NO\]~i~. (B) ISO-β~2~-AR increased \[NO\]~i~. (C) ISO-β~1~-AR had no effect on \[NO\]~i~, although 100 μM SNO elicited a prominent increase in \[NO\]~i~. (D) L-NIO blocked ISO-β~1~/β~2~-AR effects on \[NO\]~i~.](JGP8486.f6){#F6}

![Effects of zinterol on \[NO\]~i~. (A) Field stimulation (FS, arrow) had no effect on \[NO\]~i~. However, during field of stimulation, exposure to 10 μM zinterol in the presence of 0.1 μM atenolol, increased \[NO\]~i~. (B) Pretreatment with 0.1 μM ICI 118,551 blocked the effect of zinterol to increase \[NO\]~i~. (C) Pretreatment with 10 μM L-NIO blocked the effect of zinterol to increase \[NO\]~i~. (D) Zinterol (10, 1, and 0.1 μM) elicited a dose-dependent increase in \[NO\]~i~.](JGP8486.f7){#F7}

![Summary of the effects of 1 μM ISO and 10 μM zinterol on \[NO\]~i~. (A) The effects of ISO and zinterol to increase \[NO\]~i~ (control) were not significantly affected by β~1~-AR block (0.1 μM atenolol), but the effects of both agonists were abolished by β~2~-AR block (ICI 118,551) or inhibition of NO synthase (L-NIO). (B) The effects of three different zinterol concentrations (10, 1, and 0.1 μM) on \[NO\]~i~. The numbers in parentheses indicate the number of cells tested.](JGP8486.f8){#F8}

![Effect of pertussis toxin (PTX) on zinterol-mediated stimulation of NO. (A) Under control conditions, 10 μM zinterol elicited a typical increase in \[NO\]~i~. In another cell incubated in PTX, zinterol-induced increase in \[NO\]~i~ was markedly decreased. (B) Graph summarizing the effects of 10 μM zinterol on control and PTX-treated cells. The numbers in parentheses indicate the number of cells tested.](JGP8486.f9){#F9}

![Effects of Wortmannin, an inhibitor of PI-3K, on ACh-induced activation of I~K,ATP~ (A and B) and production of \[NO\]~i~ (C and D). (A) Under control conditions, after exposure to 1 μM zinterol, ACh~2~ induced a typical potentiated increase in K^+^ conductance. (B) In another cell, pretreatment with 0.2 μM Wortmannin abolished the potentiated response to ACh~2~. (C) Under control conditions, 10 μM zinterol stimulated \[NO\]~i~. In another cell, pretreatment with 0.2 μM Wortmannin abolished zinterol-mediated stimulation of \[NO\]~i~. (D) Summary graph showing that compared with control, pretreatment with either 0.2 μM Wortmannin (wort) or 10 μM LY294002 (LY) blocked zinterol-induced stimulation of \[NO\]~i~. The numbers in parentheses indicate the number of cells tested.](JGP8486.f10){#F10}

![Schematic diagram summarizing the signaling pathways coupled to both β~1~- and β~2~-ARs in cat atrial myocytes. β~1~-ARs couple exclusively via G~s~-protein to adenylate cyclase (AC) to stimulate cAMP synthesis. β~2~-ARs also couple via G~s~-protein to AC to stimulate cAMP. Whether both β~1~- and β~2~-ARs are coupled to the same G~s~-AC remains to be determined. β~2~-ARs also couple via G~i~-protein and PI-3K/Akt signaling to constitutive NO synthase (eNOS) and production of NO. NO stimulates guanylate cyclase (GC) to elicit cGMP-induced inhibition of PDE III, which raises cAMP generated by endogenous AC activity. Compartmentalized pools of cAMP generated via different β~1~- and β~2~-AR--mediated signaling pathways target regulation of L-type Ca^2+^ channels (ICa,L) and ACh-activated ATP-sensitive K^+^ channels (IK,ATP). M1-R indicates subtype 1 muscarinic receptor.](JGP8486.f11){#F11}
